Alnylam Pharmaceuticals (ALNY) Share-based Compensation (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded Share-based Compensation of $86.63 million in Q2 2026, down 22.4% from $111.68 million a year earlier but up 23.5% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Share-based Compensation (2009 - 2026) Analysis & Trends
On a TTM basis, Alnylam Pharmaceuticals' Share-based Compensation came in at $336.62 million as of Jun 30, 2026, up 10.1% year-over-year; for FY2025, it came in at $348.24 million, up 28.0% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 20.0% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $272.08 million in FY2024 (+22.7%), $221.68 million in FY2023 (-3.9%), $230.65 million in FY2022 (+39.2%) and $165.72 million in FY2021 (+18.5%).
- Quarterly Share-based Compensation has ranged from $29.29 million in Q1 2022 to $128.12 million in Q3 2022 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in five of the last eight quarters, with growth averaging 32.0%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 284.0% in Q3 2022, against a decline of 50.1% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $70.15 million (Q1 2026), $71.63 million (Q4 2025) and $108.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Alnylam Pharmaceuticals | 34.15 Bn | 22.20 Bn | 992.69 Mn | 86.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.63 Mn |
| Mar 31, 2026 | 70.15 Mn |
| Dec 31, 2025 | 71.63 Mn |
| Sep 30, 2025 | 108.21 Mn |
| Jun 30, 2025 | 111.68 Mn |
| Mar 31, 2025 | 56.71 Mn |
| Dec 31, 2024 | 91.65 Mn |
| Sep 30, 2024 | 45.80 Mn |
| Jun 30, 2024 | 89.29 Mn |
| Mar 31, 2024 | 45.35 Mn |
| Dec 31, 2023 | 41.99 Mn |
| Sep 30, 2023 | 63.94 Mn |
| Jun 30, 2023 | 75.80 Mn |
| Mar 31, 2023 | 39.95 Mn |
| Dec 31, 2022 | 42.77 Mn |
| Sep 30, 2022 | 128.12 Mn |
| Jun 30, 2022 | 30.47 Mn |
| Mar 31, 2022 | 29.29 Mn |
| Dec 31, 2021 | 44.58 Mn |
| Sep 30, 2021 | 33.37 Mn |
API Access
Alnylam Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();